1. 1) U.S. Food and Drug Administration. Guidance for Industry, Dissolution Testing of Immediate Release Solid Oral Dosage Forms. (1997).
2. 2) European Medicines Agency. Guideline on the Investigation of Bioequivalence. (2010).
3. 3) Ministry of Health. Labour and Welfare of Japan. Guideline for Bioequivalence Studies of Generic Products. (2012).
4. 4) Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm. Tech., 20, 64–74 (1996).
5. 5) Shah VP, Tsong Y, Sathe P, Liu JP. In vitro dissolution profile comparison—statistics and analysis of the similarity factor, f2. Pharm. Res., 15, 889–896 (1998).